Position in ZTS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$381,935
-$266,328 QoQ
Shares Held
5,315
-3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#846
of 1,408 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $8,299,759 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
39,698 | $4,404,096 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
65,730 | $1,617,615 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
24,799 | $897,723 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
25,398 | $797,497 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
5,315 | $381,935 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
213 | $115,409 | |
| 7 | ALKS |
Alkermes plc.
|
700 | $36,680 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,242 | $21,499 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $381,935 | 5,315 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $648,263 | 5,484 | Shares | Sole | 2026-04-28 | |
| 2024-12-31 | $1,559,077 | 9,569 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $1,823,872 | 9,335 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,610,341 | 9,289 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $1,569,084 | 9,273 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||